Srs Capital Advisors, Inc. Ptc Therapeutics, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 104 shares of PTCT stock, worth $5,768. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104
Previous 104
-0.0%
Holding current value
$5,768
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
258Shares Held
77.4MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$509 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$431 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$410 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$354 Million4.07% of portfolio
-
Wellington Management Group LLP Boston, MA4.79MShares$266 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.97B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...